|Product Name:||Tofacitinib citrate|
|Solubility:||DMSO >30 mg/mL, Water 2 mg/mL|
|HPLC:||Shows Min 98.93% purity|
|H-NMR:||Consistent with structure|
|Description:||Tofacitinib (CP-690550) Citrate is a novel inhibitor of JAK3 with IC50 of 1 nM, 20- to 100-fold less potent against JAK2 and JAK1.|
|Stability and Solubility Advice:|| Information concerning product stability, particularly in solution, has rarely been reported and in most cases we can only offer a general guide.
We recommend that stock solutions, once prepared, are stored aliquoted in tightly sealed vials and used within 1 month. Avoid repeated freeze and thaw cycles. Storage conditions for some special products should refer to their storage details.